Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | MTOR | P42345 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.61 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.61 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | HBB | P68871 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zebularine SCHEMBL12040244 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL12595413 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL13032 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL7122633 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL11910465 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL1649826 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL19656926 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL21842491 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL21474114 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB | |
| Zebularine SCHEMBL1444853 | 1.00 | CDA (1.00) | CDAMAPTLMNAMTORTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171552-A1 | USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER THERAPY | Les Laboratoires Servier (FR) | 2023-05-03 | — | — | EP | claimed |
| WO-2021262881-A1 | USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER THERAPY | SERVIER PHARMACEUTICALS, LLC (US) | 2021-12-30 | — | — | WO | claimed |
| WO-2015185611-A1 | COMPOUNDS AND METHODS FOR INCREASING THE IMMUNE RESPONSE TO PAPILLOMAVIRUS | UNIVERSITÄTSKLINIKUM HEIDELBERG (DE) | 2015-12-10 | — | — | WO | claimed |
| EP-2952182-A1 | Compounds and methods for increasing the immune response to papillomavirus | Universitätsklinikum Heidelberg (DE) | 2015-12-09 | — | — | EP | claimed |
| WO-2023237710-A1 | CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2023-12-14 | — | — | WO | disclosed |
| WO-2020231937-A1 | IRF2 AS A PROGNOSTIC BIOMARKER AND TARGET FOR AUGMENTING IMMUNOTHERAPY | UNIVERSITY OF MASSACHUSETTS (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-3509570-A1 | TABLET COMPOSITIONS | Celgene Corporation (US) | 2019-07-17 | — | — | EP | disclosed |
| WO-2018048847-A1 | TABLET COMPOSITIONS | CELGENE CORPORATION (US) | 2018-03-15 | — | — | WO | disclosed |
| WO-2017035453-A1 | COMPOSITIONS AND METHODS FOR TREATING SOLID TUMORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-03-02 | — | — | WO | disclosed |
| WO-2015185611-A1 | COMPOUNDS AND METHODS FOR INCREASING THE IMMUNE RESPONSE TO PAPILLOMAVIRUS | UNIVERSITÄTSKLINIKUM HEIDELBERG (DE) | 2015-12-10 | — | — | WO | disclosed |
| EP-2952182-A1 | Compounds and methods for increasing the immune response to papillomavirus | Universitätsklinikum Heidelberg (DE) | 2015-12-09 | — | — | EP | disclosed |
| WO-2015139013-A1 | FUNCTIONAL SCAFFOLD FOR TISSUE REPAIR AND REGENERATION | HAN BO (US) | 2015-09-17 | — | — | WO | disclosed |
| US-6280936-B1 | USEFUL FOR CLEAVAGE OF RIBONUCLEIC ACID (RNA) AND DEOXYRIBONUCLEIC ACID | RIBOZYME PHARMACEUTICALS, INC. | 2001-08-28 | — | — | US | disclosed |
| EP-1098969-A2 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 2001-05-16 | — | — | EP | disclosed |
| EP-0980424-A2 | ENZYMATIC NUCLEIC ACIDS: SYNTHESIS, SELECTION AND USE | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-02-23 | — | — | EP | disclosed |
| WO-2000004141-A2 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-01-27 | — | — | WO | disclosed |
| WO-1998050530-A9 | ENZYMATIC NUCLEIC ACIDS: SYNTHESIS, SELECTION AND USE | RIBOZYME PHARM INC (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998050530-A2 | ENZYMATIC NUCLEIC ACIDS: SYNTHESIS, SELECTION AND USE | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1995024185-A1 | NOVEL PYRIMIDINE NUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 1995-09-14 | — | — | WO | disclosed |
| US-4990499-A | Treatment of infections and neoplasms | UNIVERSITY OF SASKATCHEWAN (CA) | 1991-02-05 | — | — | US | disclosed |